Clinical care and treatment services for kidney cancer at UCLA is facilitated through the UCLA Kidney Cancer Program.
About the Program
Established in 1989, the UCLA Kidney Cancer Program provides state-of-the-art medical, surgical and mindful care to our patients with kidney cancer, in a convenient and coordinated multidisciplinary setting, while working to advance and discover more effective treatments and an ultimate cure for kidney cancer.
The UCLA Kidney Cancer Program is a unique, comprehensive, multidisciplinary program developed by the UCLA Departments of:
- Urology, Division of Urologic Oncology
- Department of Medicine, Division of Hematology/Oncology
The UCLA Kidney Cancer Program's team of physicians, surgeons and clinical professionals are world-renowned experts in the diagnosis, management and treatment of kidney cancer, from localized tumors (tumors confined to the kidney) to the most complicated metastatic kidney tumors (tumors that have spread to other organs or parts of the body).
|The UCLA Kidney Cancer Program Team|
A strong affiliation and collaborative approach with two of the world’s foremost cancer and research institutions, UCLA’s Jonsson Comprehensive Cancer Center and The David Geffen School of Medicine at UCLA, gives the Program the ability to offer patients unique access to world leaders in cancer research.
Clinical trials are carefully controlled research studies in which cancer patients help doctors and scientists find ways to improve health and cancer care, and to make sure the treatments are safe and effective. Each study is designed to address and answer specific scientific questions and to find better ways to prevent, diagnose or treat cancer. A clinical trial is one of the final stages resulting from the research conducted during intensive and lengthy laboratory studies.
There are many promising non-standard therapies being studied in UCLA's Kidney Cancer Program, which include cellular immune therapy (dendritic cell therapy, autolymphocyte therapy, tumor infiltrating lymphocytes, etc), tumor vaccines, gene therapy, stem cell transplant, anti-angiogenesis therapy, inhibitors of growth factors, etc.
If you are interested in finding out more about these studies, search our listings of currently open clinical trials.
For further information on the UCLA Kidney Cancer Program, visit the following links: